CN Bio Awarded Innovate UK Grant to Develop Single and Multi-organ Models for COVID-19 Research

03 Mar, 2021

CN Bio Awarded Innovate UK Grant to Develop Single and Multi-organ Models for COVID-19 Research
Photo by Ryoji Iwata on Unsplash

– CN Bio announced a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
– The funding will be used to develop and test advanced cell culture models that represent different regions of the lung and subsequently linking these models to other organ systems, such as liver and gut, to inform the rapid development of novel therapeutics.
– The fast-moving nature of the COVID-19 pandemic directs additional pressure onto current drug discovery and development processes, which can be limited by misrepresentative in vivo models that cause a large proportion of new medicines to fail when taken to clinical trials.
– To circumvent this, CN Bio is developing single and multi-organ COVID-19 models to investigate virology and immunology throughout the body, with a prolonged viable cell culture time for extended studies.

Biopharma Biotechnology Europe Health Care Life Science Medical Medical Device
Crunchbase icon

Content report

The following text will be sent to our editors: